Skip to main content

Recent News

  • ACRmtg.jpg (keep)
    EULAR treats its attendees to a wonderful lunch each day – Schnitzel, gnocchi, goulash at lunch after muffins and coffee in the morning. It's no wonder the meeting has been a lively one, well attended with a wealth of stimulating ideas, research and discussion. Here are a few of my favorite abstracts and presentations from today, day 3 in Vienna.
    Read Article
How many #autoantibodies Does one need in #rheumatoid #arthritis Need 4 citrullinated peptides Covers off 97% of IgG CVP2 ACPAs #EULAR2024 @RheumNow @eular_org https://t.co/LNFGuFXGrC

Janet Pope @Janetbirdope (  View Tweet)

Once in remission with #rituximab in #GPA How long to resize 500 mg q6 mo for 4 years? ?longer ?less #EULAR2024 @eular_org @RheumNow https://t.co/G4kU3v81je

Janet Pope @Janetbirdope (  View Tweet)

Telespa - telemonitoring in AxSpA « minimal impact on disease control « never examine a patient again , never find any pathology outside of joints, remote SpAologists, no longer physicians - easy to train rheumatology nurses to do our jobs @RheumNow #EULAR2024

Peter Nash @drpnash (  View Tweet)

PMR has distinct patterns on MRI shoulder, possibly helping diagnosis. #EULAR2024 OP0248 @RheumNow also @bmj_rmdopen https://t.co/pS5kO5OQRW where they say: "Similar to our prior findings... the target of inflammation in PMR is the outer covering of a tendon, the peritendineum" https://t.co/5pu1Xiku3h
David Liew @drdavidliew (  View Tweet)
EULAR 2024 Highlights: Saturday’s Recap with RheumNow https://t.co/BlOsbr9lYB

Dr. John Cush @RheumNow (  View Tweet)

RheumNow’s expanded coverage of the #EULAR2024 Annual meeting is sponsored in part by Bristol Myers Squibb and UCB. All content is chosen by RheumNow & its faculty.

Dr. John Cush @RheumNow (  View Tweet)

#EULARBEST RCT of #upadacitinib in #GCA It works to steroid spare 15 mg > 7.5 mg in outcomes Both >>placebo Ethically PBO had slower #prednisone taper Similar to #TCZ data What to choose in GCA IL6i IL17i JAKi @eular_org @RheumNow LBA0001 https://t.co/gy0TEiHxjo

Janet Pope @Janetbirdope (  View Tweet)

Does B Cell Depletion Matter? Dr. Yuz Yusof interviews Dr. Ed Vital regarding abstract OP0077 at Eular 2024 in Vienna, Austria. https://t.co/IjxGWWjoGD https://t.co/GwLjB4Z7ub
Dr. John Cush @RheumNow (  View Tweet)
Telespa - telemonitoring in AxSpA « minimal impact on disease control « never examine a patient again , never find any pathology outside of joints, remote SpAologists, no longer physicians - easy to train rheumatology nurses to do our jobs @RheumNow #EULAR2025

Peter Nash @drpnash (  View Tweet)

#Scleroderma #recommendations #Rayanud’s #vasculopathy #digital #ulcers CCB PDE5i IV iloprost Bosentan for Digital ulcer prevention <not approved in NA> #EULAR2024 @EUSTAR_org @RheumNow #SSc https://t.co/9c2cHAptIC
Janet Pope @Janetbirdope (  View Tweet)
SHR032 chinese JAK1 inhib AS and PsA - typical efficacy and safety - looks like smells like tastes like JAK1 inhib but no zoster listed or acne, or anaemia with higher dose, 1 mace 1 vte @RheumNow #EULAR2024

Peter Nash @drpnash (  View Tweet)

Duo IL17A,F #SONELOKIMAB RCT in active #PsA ACR50 around 46% Nanobody to me it looks like #Bimekizumab results So far low #fungal infections OP0195 We are over run with + IL17i RCTs in #psoriatic #arthritis Impt~market /access/risk/benefit? #EULAR2024 @eular_org @RheumNow

Janet Pope @Janetbirdope (  View Tweet)

Ixokibep a small IL17Ai works in #PsA 16 wks ▶️50% had PASI 100 Fast 40-42% ACR50 Same rate of MDA Helped enthesitis also ⬆️injection site rx’n Wow! But where to use vs 2 other IL17Ai and IL17AEi LB0005 #EULAR24 @eular_org @RheumNow

Janet Pope @Janetbirdope (  View Tweet)

The electronic nose, knows? Exhaled breath volatile organic compounds do surprisingly well in diagnosing RA. Really… takes your breath away (as seen in @rheuma_doktorin’s highlights) #EULAR2024 POS0652 @RheumNow https://t.co/OCRHdZZS3Q
David Liew @drdavidliew (  View Tweet)
Periodontal disease is a major factor in the development of RA - and that’s the tooth! in ACPA+ clinically suspect arthralgias, tooth extraction: adjusted HR 3.10 Population-level dental care? (as seen in @rheuma_doktorin’s highlights) #EULAR2024 POS0467 @RheumNow https://t.co/wN8bvBtv40
David Liew @drdavidliew (  View Tweet)
The MRI SIJ findings in postpartum patients with buttock/pelvic pain remain stable in a 7 year follow up study. They rarely develop classical MRI features of axial SpA (i.e. erosion, fat > 1 cm in depth, backfill and ankylosis) or are diagnosed as axial SpA within an 8-year… https://t.co/8M0FP65KPS https://t.co/k1ruzjC7Zy
Dr. Antoni Chan @synovialjoints (  View Tweet)
Four phenotypes of chronic back pain suspicious of axial spondyloarthritis (axSpA) in the SPACE cohort. These groups were: They were “axial”, “axSpA with peripheral signs”, “at risk” and “no SpA”. Over a 2 year follow up, Transitions between the four classes over two years were… https://t.co/lF1wtAo46Q https://t.co/BXj1nw0tto
Dr. Antoni Chan @synovialjoints (  View Tweet)
Planetary health session #EULAR2024 Need to consider these in managing patients. We in healthcare are contributing to emissions significantly! @RheumNow https://t.co/Gxyrm5drCE
Bella Mehta @bella_mehta (  View Tweet)
PMR patients get too much steroid. Data across 27 million people in England, n=39,438 with PMR. The blue are getting more pred than guidelines. Like everything in rheum: we need to be giving less pred, not more. Lumping PMR in with GCA won’t help. #EULAR2024 POS0411 @RheumNow https://t.co/bsi3lrAafm
David Liew @drdavidliew (  View Tweet)